Caribou Biosciences, Inc. financial data

Symbol
CRBU on Nasdaq
Location
2929 7 Th Street, Suite 105, Berkeley, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 676 % -29.3%
Debt-to-equity 28.9 % +48.8%
Return On Equity -80.8 % -77.7%
Return On Assets -62.7 % -64.6%
Operating Margin -1.71K % -18.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 93.5M shares +3.22%
Common Stock, Shares, Outstanding 93.5M shares +3.22%
Entity Public Float 141M USD -46.3%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 93.3M shares +3.14%
Weighted Average Number of Shares Outstanding, Diluted 93.3M shares +3.14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.3M USD -19%
Research and Development Expense 116M USD -11.4%
General and Administrative Expense 39.8M USD -12.8%
Operating Income (Loss) -159M USD +3.89%
Nonoperating Income (Expense) 1.63M USD -90.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -157M USD -6.08%
Earnings Per Share, Basic -1 USD/shares -7.6%
Earnings Per Share, Diluted -1 USD/shares -7.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.1M USD -65.1%
Cash, Cash Equivalents, and Short-term Investments 159M USD -43.3%
Accounts Receivable, after Allowance for Credit Loss, Current 242K USD +31.5%
Assets, Current 156M USD -34.5%
Property, Plant and Equipment, Net 7.6M USD -61.2%
Operating Lease, Right-of-Use Asset 16M USD -21.9%
Other Assets, Noncurrent 3.78M USD -20.3%
Assets 195M USD -43.4%
Accounts Payable, Current 3.8M USD +40.7%
Employee-related Liabilities, Current 6.52M USD -8.07%
Accrued Liabilities, Current 19.4M USD -24%
Contract with Customer, Liability, Current 2.22M USD -21.6%
Liabilities, Current 28.1M USD -12.8%
Contract with Customer, Liability, Noncurrent 1.76M USD -55.5%
Deferred Income Tax Liabilities, Net 548K USD -1.62%
Operating Lease, Liability, Noncurrent 22.8M USD -10.5%
Liabilities 53.1M USD -15.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 93K USD -88.2%
Retained Earnings (Accumulated Deficit) -570M USD -38.1%
Stockholders' Equity Attributable to Parent 142M USD -49.6%
Liabilities and Equity 195M USD -43.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.7M USD +1.29%
Net Cash Provided by (Used in) Financing Activities 468K USD -96.3%
Net Cash Provided by (Used in) Investing Activities 49.4M USD +115%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 93.5M shares +3.22%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.2M USD -65%
Deferred Tax Assets, Valuation Allowance 147M USD +53.2%
Deferred Tax Assets, Gross 155M USD +47.6%
Operating Lease, Liability 26.5M USD -2.29%
Payments to Acquire Property, Plant, and Equipment 1.04M USD -28%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -158M USD -7.84%
Lessee, Operating Lease, Liability, to be Paid 38.1M USD -8.75%
Property, Plant and Equipment, Gross 20.5M USD -34.7%
Operating Lease, Liability, Current 2.69M USD +128%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.72M USD +27.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.31M USD +23.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.6M USD -20.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.92M USD +3.53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.01M USD +95.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.12M USD +3.38%
Operating Lease, Payments 711K USD -35%
Additional Paid in Capital 712M USD +2.66%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.17M USD +64.1%
Deferred Tax Assets, Net of Valuation Allowance 7.54M USD -14%
Share-based Payment Arrangement, Expense 13.9M USD -15.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%